Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (21906)	6/5/1998 4:12:00 PM
From: RXGOLF	Read Replies (1) \| Respond to of 32384

<<compounds can be made and modified very cheaply. >> Robert, this may not be completely accurate, but Henry may be referring to making very small changes to a compound, and thus keeping the same physiological activity, but then calling it your own and sell it for similar activity to the original compound(did that make sense?). For a rough idea, think of the umpteen ACE inhibitors on the market. Many companies own one, sell one, but they all work in the same way and are similar(with small changes). Hope that kind of helps and hope that is what Henry was referring to, Greg